234 related articles for article (PubMed ID: 16810047)
1. Recombinant factor VIIa and the surgical patient.
Scarpelini S; Rizoli S
Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Manning BJ; Hynes N; Courtney DF; Sultan S
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
Levi M; Peters M; Büller HR
Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
Benharash P; Bongard F; Putnam B
Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
[TBL] [Abstract][Full Text] [Related]
6. Current evidence based guidelines for factor VIIa use in trauma: the good, the bad, and the ugly.
Duchesne JC; Mathew KA; Marr AB; Pinsky MR; Barbeau JM; McSwain NE
Am Surg; 2008 Dec; 74(12):1159-65. PubMed ID: 19097529
[TBL] [Abstract][Full Text] [Related]
7. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa in massive postpartum haemorrhage.
Karalapillai D; Popham P
Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
[TBL] [Abstract][Full Text] [Related]
9. Factor VIIa (recombinant) for acute traumatic hemorrhage.
Patanwala AE
Am J Health Syst Pharm; 2008 Sep; 65(17):1616-23. PubMed ID: 18714107
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa: review of current "off license" indications and implications for practice.
Rose L
AACN Adv Crit Care; 2007; 18(2):141-8. PubMed ID: 17473542
[TBL] [Abstract][Full Text] [Related]
11. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
12. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
Johnson SJ; Ross MB; Moores KG
Am J Health Syst Pharm; 2007 Sep; 64(17):1808-12. PubMed ID: 17724361
[TBL] [Abstract][Full Text] [Related]
13. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
[TBL] [Abstract][Full Text] [Related]
14. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
Hardy JF
Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
[No Abstract] [Full Text] [Related]
15. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
16. Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Hong I; Stachnik J
Am J Health Syst Pharm; 2010 Nov; 67(22):1909-19. PubMed ID: 21048207
[TBL] [Abstract][Full Text] [Related]
17. Treatment of critical bleeding in trauma patients.
Chiara O; Cimbanassi S; Brioschi PR; Bucci L; Terzi V; Vesconi S
Minerva Anestesiol; 2006 Jun; 72(6):383-7. PubMed ID: 16682905
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Grounds M
Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
[TBL] [Abstract][Full Text] [Related]
19. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.
Vincent JL; Rossaint R; Riou B; Ozier Y; Zideman D; Spahn DR
Crit Care; 2006; 10(4):R120. PubMed ID: 16919168
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa in the treatment of non-hemophiliac bleeding.
Lam MS; Sims-McCallum RP
Ann Pharmacother; 2005 May; 39(5):885-91. PubMed ID: 15784806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
